5
Hiran Orgochem
506170 BSE
Hiran Orgochem
Healthcare BSE: 506170 Pharmaceuticals & Biotechnology
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company has reduced debt.
Weaknesses
3- The company has delivered a poor sales growth of -70.9% over past five years.
- Company has high debtors of 322 days.
- Working capital days have increased from 1,638 days to 2,355 days
Growth Rate
Revenue Growth
-100% lower than
3Y
Net Income Growth
103% higher than
3Y
Quarterly Results
| Particulars | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.22 | 2.56 | 0.09 | 0 | 0.24 | 0 | 0.14 | 0.05 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 40.07 | 2.76 | 0.3 | 6.04 | 0.34 | 0.14 | 0.3 | 30.29 | 0 | 0.11 | -0.34 | 0.12 | 0.06 |
| Operating Profit | -35.85 | -0.2 | -0.21 | -6.04 | -0.1 | -0.14 | -0.16 | -30.24 | 0 | -0.11 | 0.34 | -0.12 | -0.06 |
| OPM % | -849.53% | -7.81% | -233.33% | — | -41.67% | — | -114.29% | -60480% | — | — | — | — | — |
| Other Income | 1.62 | 0.27 | 0.27 | 0.38 | 0 | 0.02 | 0.11 | 0.69 | 0 | 0 | 0 | 0.93 | 0 |
| Interest | 0.01 | 0 | 0 | 0.18 | 0 | 0 | 0 | -0.07 | 0 | 0 | 0 | 0.06 | 0 |
| Depreciation | 0.58 | 0.62 | 0.62 | 0.27 | 0 | 0 | 0 | 0.05 | 0 | 0.03 | 0.01 | 0.01 | 0.01 |
| PBT | -34.82 | -0.55 | -0.56 | -6.11 | -0.1 | -0.12 | -0.05 | -29.53 | 0 | -0.14 | 0.33 | 0.74 | -0.07 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — | 0% | 0% | 0% | 0% |
| Net Profit | -34.82 | -0.55 | -0.56 | -6.11 | -0.1 | -0.12 | -0.05 | -29.53 | 0 | -0.14 | 0.33 | 0.73 | -0.07 |
| EPS in Rs | -3.53 | -0.06 | -0.06 | -0.62 | -0.01 | -0.01 | -0.01 | -2.99 | 0 | -0.01 | 0.03 | 0.07 | -0.01 |
Profit & Loss
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Jun 2011 15m | Jun 2012 | Jun 2013 9m | Mar 2014 | Mar 2015 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 113 | 108 | 119 | 188 | 203 | 148 | 38.91 | 23.96 | 2.62 | 0.42 | 0 |
| Expenses | 88.58 | 100 | 108 | 203 | 190 | 215 | 50.99 | 82.59 | 9.08 | 8.32 | -0.05 |
| Operating Profit | 24.13 | 7.65 | 11.71 | -14.73 | 12.86 | -67.23 | -12.08 | -58.63 | -6.46 | -7.9 | 0.05 |
| OPM % | 21.41% | 7.09% | 9.81% | -7.82% | 6.34% | -45.51% | -31.05% | -244.7% | -246.56% | -1880.95% | — |
| Other Income | 1.08 | 1.83 | 2.67 | 1.62 | 9.07 | 2.81 | 7.64 | 1.47 | 0.93 | -19.79 | 0.93 |
| Interest | 3.62 | 5.18 | 7.57 | 9.99 | 9.09 | 15.22 | 1.9 | 0.08 | 0.18 | 0.01 | 0.06 |
| Depreciation | 1.26 | 1.62 | 1.83 | 2.12 | 2.33 | 3.2 | 2.76 | 2.77 | 1.51 | 0.05 | 0.06 |
| PBT | 20.33 | 2.68 | 4.98 | -25.22 | 10.51 | -82.84 | -9.1 | -60.01 | -7.22 | -27.75 | 0.86 |
| Tax % | 34.19% | 59.7% | 22.09% | -31.09% | 29.12% | 0.65% | 0% | 0% | 0% | 0% | — |
| Net Profit | 13.38 | 1.08 | 3.88 | -17.38 | 7.45 | -83.38 | -9.09 | -60.01 | -7.22 | -27.76 | 0.85 |
| EPS in Rs | 3.47 | 0.21 | 0.74 | -3.31 | 1.42 | -8.45 | -0.92 | -6.08 | -0.73 | -2.81 | 0.08 |
| Div. Payout % | 8.65% | 48.61% | 13.53% | -1.21% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Mar 2014 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.72 | 10.5 | 10.5 | 10.5 | 52.5 | 98.66 | 98.66 | 98.66 | 98.66 | 98.66 |
| Reserves | 39.34 | 73.69 | 76.96 | 61 | 26.44 | -56.94 | -66.03 | -126 | -133 | -161 |
| Borrowings | 32.75 | 47.89 | 56.67 | 51.62 | 53.7 | 96.15 | 89.05 | 88.76 | 85.71 | 65.45 |
| Other Liabilities | 39.81 | 44.35 | 57.5 | 65.66 | 89.66 | 55.67 | 30.87 | 25.48 | 24.5 | 22.41 |
| Total Liabilities | 120 | 176 | 202 | 189 | 222 | 194 | 153 | 86.86 | 75.61 | 25.5 |
| Fixed Assets | 27.56 | 31.68 | 35.95 | 36.53 | 37.04 | 38.78 | 35.58 | 33.08 | 31.57 | 0.2 |
| CWIP | 1.22 | 0.57 | 2.27 | 1.26 | 0.14 | 0.04 | 0.04 | 0.04 | 0 | 0 |
| Investments | 1.52 | 0.78 | 0.89 | 2.9 | 4.8 | 4.69 | 4.69 | 4.59 | 4.59 | 0 |
| Other Assets | 89.32 | 143 | 163 | 148 | 180 | 150 | 112 | 49.15 | 39.45 | 25.3 |
| Total Assets | 120 | 176 | 202 | 189 | 222 | 194 | 153 | 86.86 | 75.61 | 25.5 |
Cash Flow
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Mar 2014 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -17.59 | -41 | 4.58 | 20.73 | 11.9 | -56.67 | 9.59 | -28.64 | -0.92 | -16.08 |
| Investing | -9 | -3.24 | -6.58 | -2.6 | -1.29 | -1.1 | 2.28 | 1.11 | 0.96 | 16.13 |
| Financing | 27.23 | 45.84 | 1.87 | -15.32 | -8.97 | 73.97 | -9.01 | -0.34 | 0 | 0 |
| Net Cash Flow | 0.64 | 1.6 | -0.13 | 2.81 | 1.64 | 16.2 | 2.86 | -27.87 | 0.04 | 0.05 |
| Free Cash Flow | -24.83 | -46.04 | -3.23 | 18.49 | 9.98 | -61.78 | 9.88 | -28.63 | -0.87 | -5.42 |
| CFO/OP | -56 | -496 | 48 | -144 | 94 | 84 | -81 | 51 | 14 | 204 |
Ratios
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Jun 2011 | Jun 2012 | Jun 2013 | Mar 2014 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 63.67 | 58.46 | 89.01 | 34.31 | 74.58 | 73.47 | 186 | 119 | 1,159 | 322 |
| Inventory Days | 205 | 260 | 262 | 105 | 147 | 23.77 | 39.69 | 17.12 | 154 | 930 |
| Days Payable | 133 | 131 | 189 | 124 | 161 | 89.83 | 266 | 350 | 3,212 | 17,598 |
| Cash Conversion Cycle | 136 | 188 | 162 | 15.34 | 60.32 | 7.42 | -40.42 | -214 | -1,899 | -16,347 |
| Working Capital Days | 159 | 331 | 319 | 138 | 145 | 170 | 498 | 359 | 2,062 | 2,355 |
| ROCE % | — | 7.34% | 9.09% | -11.37% | 15.48% | -49.65% | -5.31% | -65.43% | -8.16% | -26.09% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Hiran Orgochem insights
55 extracted metrics + investor summaries across FY06–FY15.
Documents
1
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
5m - Siyaram Recycling attended Arihant Bharat Connect Rising Stars 2026; no UPSI shared; uploaded to website. 5m - Siyaram Recycling attended Arihant Bharat Connect Rising Stars 2026; no UPSI shared; uploaded to website.
2
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2 Mar - Of Schedule of Analyst / Institutional Investor Meeting s under the SEBI ( Listing Obligations and Disclousure Rquirements) Regulations 2015 2 Mar - Of Schedule of Analyst / Institutional Investor Meeting s under the SEBI ( Listing Obligations and Disclousure Rquirements) Regulations 2015
3
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
25 Feb - Siyaram Recycling secured Rs.1,99,60,290 Brass Scrap Honey order from Anurag Impex, execution within seven days. 25 Feb - Siyaram Recycling secured Rs.1,99,60,290 Brass Scrap Honey order from Anurag Impex, execution within seven days.
4
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
16 Feb - Siyaram Recycling secured Rs.2,04,00,831 order from Charbhuja Impex for Brass Scrap Honey, execution within six months. 16 Feb - Siyaram Recycling secured Rs.2,04,00,831 order from Charbhuja Impex for Brass Scrap Honey, execution within six months.
5
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
11 Feb - Siyaram Recycling secured Rs.1,88,53,332 Brass Scrap Honey order from Charbhuja Impex; execution within six months. 11 Feb - Siyaram Recycling secured Rs.1,88,53,332 Brass Scrap Honey order from Charbhuja Impex; execution within six months.
Frequently Asked Questions about Hiran Orgochem
What does Hiran Orgochem Ltd do?
Hiran Orgochem is a leading integrated manufacturer of active pharmaceutical ingredients and formulations.
Where is Hiran Orgochem Ltd (506170) listed?
Hiran Orgochem Ltd trades under code 506170 on the BSE.
Which sector does Hiran Orgochem Ltd belong to?
Hiran Orgochem Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.
Company Information
Hiran Orgochem is a leading integrated manufacturer of active pharmaceutical ingredients and formulations.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/506170.md for Hiran Orgochem Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.